As it turns out, all the scientists and doctors who insisted that Merck's "Revolutionary" COVID drug molnupiravir is extremely safe weren't faithfully adhering to "The science" after all.
It's perfectly understandable why Merck might choose to play down this safety risk: assuming it's approved, the drug is widely expected to be one of "The most lucrative drugs ever" - which is one reason why Merck's shares soared into double-digit territory after the announcement.
According to Barron's, some scientists who have studied the drug believe that its method of suppressing the virus could potentially run amok within the body.
Some scientists who have studied the drug warn that the method it uses to kill the virus that causes Covid-19 carries potential dangers that could limit the drug's usefulness.
In particular, Raymond Schinazi, a professor of pediatrics and the director of biochemical pharmacology at Emory who studied the drug while it was being developed, and published a number of papers on NHC, the compound that's the active ingredient in the drug.
Still, scientists and doctors who have studied NHC say that Merck needs to "Be careful," and it's not just Schinazi warning about the drug's potential risks.
Merck hasn't yet released any data from its animal studies, but the scientists believe that it would take long-term studies to show that the drug is truly totally safe.
Friday, October 8, 2021
Merck's COVID 'Super Drug' Poses Serious Health Risks, Scientists Warn
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment